Stock Price Quote

MARKSANS PHARMA LTD.

NSE : MARKSANSBSE : 524404ISIN CODE : INE750C01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE74.404.65 (+6.67 %)
PREV CLOSE ( ) 69.75
OPEN PRICE ( ) 70.95
BID PRICE (QTY) 74.35 (556)
OFFER PRICE (QTY) 74.45 (305)
VOLUME 1984381
TODAY'S LOW / HIGH ( )70.55 76.85
52 WK LOW / HIGH ( )18.05 69.95
NSE74.604.95 (+7.11 %)
PREV CLOSE( ) 69.65
OPEN PRICE ( ) 71.00
BID PRICE (QTY) 74.60 (8865)
OFFER PRICE (QTY) 74.65 (472)
VOLUME 19351160
TODAY'S LOW / HIGH( ) 70.35 76.90
52 WK LOW / HIGH ( )18.05 70
BSE NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1992
Management Info
Mark Saldanha - Chairman Mark Saldanha - Managing Director
Registered Office

Address 11th Floor, " Grandeur ",Opp. Gundeecha Symphony, Veera Desai Extension Road,Oshiwara, Andheri (W),
Mumbai,
Maharashtra-400053

Phone 022- 40012000

Email companysecretary@marksanspharma.com

Website www.marksanspharma.com

Registrars Details
Bigshare Services Pvt Ltd
Bharat Tin Works Building,1st floor, Opp. Vasant Oasis,Andheri (E),Mumbai
 Listing : BSE, NSE

NEWS

28Jan Board Meeting Intimation for Notice O
MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Di..
05Oct Marksans Pharma expands recalls of met
Marksans Pharma is voluntarily expanding its earlier initiated recall on..
08Jun Marksans Pharma gains on recalling one
Marksans Pharma is currently trading at Rs. 32.45, up by 0.65 points or..
08Jun Marksans Pharma recalls one batch of M
Marksans Pharma has issued voluntary recall of one batch of Metformin Ex..
11Feb Marksans Pharma receives EIR from USFD
Marksans Pharma has received Establishment Inspection Report (EIR) from..
MORE

Financials

in Millions
QTR Dec 20 ANNUAL 20
Net Profit291.02379.03
Gross Profit 359.91 527.27
Operating Profit 411.23716.63
Net Sales 1684.554334.15
MORE

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

TTK Healthcare (BSE)
peergroup  708.20 (15.72%)
M.Cap ( in Cr)1010.32
Orchid Pharma (BSE)
peergroup  1623.40 (5.00%)
M.Cap ( in Cr)6626.13
Astrazeneca Pharma I (BSE)
peergroup  4370.00 (1.79%)
M.Cap ( in Cr)11097.63
SMS Lifesciences (BSE)
peergroup  664.70 (7.66%)
M.Cap ( in Cr)190.18
Hester Biosciences (BSE)
peergroup  2208.00 (2.17%)
M.Cap ( in Cr)1857.05
MORE

Shareholding Pattern

PROMOTERS 48.25%
NON-INSTITUTION 47.07%
FII 1%
MUTUAL FUNDS/UTI 0.09%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
MORE

Mf Holdings

Scheme NameHold(%)
Quant Small Cap Fund(G)1.11
MORE

About Marksans Pharma Ltd.

Marksans Pharma Ltd. was incorporated in the year 1992. Its today's share price is 74.4. Its current market capitalisation stands at Rs 3125.11 Cr. In the latest quarter, company has reported Gross Sales of Rs. 4334.15 Cr and Total Income of Rs.4335.88 Cr. The company's management includes Harshavardhan Panigrahi, Abhinna Sundar Mohanty, Digant Mahesh Parikh, Seetharama Raju Buddharaju, Varddhman Vikramaditya Jain, Sandra Saldanha, Mark Saldanha, Mark Saldanha.

It is listed on the BSE with a BSE Code of 524404 , NSE with an NSE Symbol of MARKSANS and ISIN of INE750C01026. It's Registered office is at 11th Floor, " Grandeur ",Opp. Gundeecha Symphony, Veera Desai Extension Road,Oshiwara, Andheri (W)Mumbai-400053, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Bhuta Shah & Co LLP, NK Mittal & Associates, VS Lalpuria & Co

download beyond app
About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang
Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading
Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays
Derivatives Updates Market Report Overview
IPO IPO Issues Performance News & Analysis
Commodities Market Movers News & Commentary MCX / NCDEX Holidays
Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Annual Return 2018 Annual Return 2017 Mutual Fund Terms & Conditions Mutual Privacy Policy
Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research
Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap
Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances SEBI ScoresRMS Policy
Connect with Us
ATTENTION INVESTORS Depository IPO KYC
Inactive account treatmentNBSPL Policy of AMLNBEPL Policy of AMLNBCPL Policy of AMLNBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar UpdationNirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019
Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300
For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain.     |    

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

AppleApp Store GooglePlay Store
AppleApp StoreGooglePlay Store
Support
Videos